We provide customized lyophilization services and develop efficient freeze-drying cycles for various biotech drugs
HTD provides customized lyophilization services and development in the San Francisco Bay area. Our complete lyophilization services include:
Freeze-drying
We provide customized lyophilization services and develop efficient freeze-drying cycles for various biotech drugs ranging from small molecules, peptides, proteins, and drug delivery systems (e.g liposomes). Our expertise and experience in thermal analysis and solid state characterization helps us in developing robust lyophilized formulations and freeze-drying cycles that can be efficiently tech-transferred to cGMP manufacturing facilities. Similar approaches are also applied to spray drying of drug products. HTD lyophilization flyer
Formulation development and lyophilization
of proteins, peptides, DNA, RNA, antibodies, antibody-polymer conjugates, vaccines, liposomes, diagnostic kits and small molecules.
Lyophilization Cycle Development
We characterize the pre-lyo solution by Differential Scanning Calorimetry (DSC) to determine glass transition temperature or collapse temperature in the frozen concentrate (Tg’). We then use a lab scale Vertis freeze-dryer to lyophilize the product. The product is usually sealed under vacuum or under a flow of an inert gas such as Nitrogen.
Characterization of solid-state properties
We use DSC and Karl Fischer to monitor solid-state structure (amorphicity) and moisture content of the lyophilized cake, respectively. The cakes are also reconstituted and reconstitution time is measured. The cakes are reconstituted and the molecular conformation of the API and its bioactivity is compared before and after lyophilization. Our experience in lyophilization and detailed characterization of the product during lyo development provides our clients with the necessary information for rationalizing the lyophilization cycle during development.
Stability studies
Lyophilized cakes are stored at cold, under ambient or accelerated condition and their stability is determined by different techniques.
Fill Finish For Tox Studies
We provide manufacturing of TOX lots for GLP testing. We use a Vertis pilot scale lyophilizer (Genesis 12 XL) with a capacity of 1,000 vials (3 mL). HTD has successfully manufactured several Tox lots for its customers.
Scale-up of Lyo cycles
Successful scale-up to a large production size dryer is critical for developing a pharmaceutically acceptable product. Using our specially configured lyophilizer, we develop a robust lyo cycle that can be easily tech-transferred to a production scale.
Tech Transfer to large GMP lyophilizers
HTD has successfully lyophilized numerous drug products and transferred the process into manufacturing. Our pilot scale lyophilizer is specifically designed to mimic large production lyophilizers. We provide a rationale approach to the lyophilization cycle that becomes a critical component of the CMC section for submission to the regulatory agencies and manufacturing groups
Lyophilization Process
Lyophilization Cycle
Lyophilization comprises of a series of process steps that include
Freezing at a controlled rate to ensure minimal perturbation of protein structure
Annealing of the frozen matrix to ensure a consistent frozen matrix across the vials
Primary drying to sublime the bulk water from the frozen matrix
Secondary drying to remove more tightly bound water molecules, ensure low moisture content in the product, and have the right solid-state properties in the final lyophile to obtain a stable product
Criteria for a Stable Lyophilized Biopharmaceutical
A glass transition temperature above the storage temperature
Moisture content below 2 %
Maintain as much native structure of the protein in the solid-state
Minimize phase separation of the protein from the amorphous phase
HTD is a private company located in Livermore, California. HTD has worked and collaborated with other companies, governments, and academia. Our researchers have helped other companies develop their products.
